statecampaign

Our comments on the much anticipated tax reform plan:

"Already, our loophole-ridden corporate tax code is rigged for big companies and their armies of tax lawyers. Not only does this plan do nothing about the worst part of our tax code -- that it rewards hiding profits offshore -- it makes it worse ... "

The Trump White House previewed part of their infrastructure, and Senate Democrats have countered with a plan on its own.

While we don't know exactly what the administration is planning, during the campaign they offered an overview of a plan that focused on tax breaks for private developers. Over the last few days, a list of possible projects was leaked which appear to be at odds with that earlier overview.

Fair Share supports investing in infrastructure, prioritizing repair, maintenance, long-term sustainability and expanding access to economic opportunities.

The makers of EpiPen testified in front of Congress -- and it was an epic fail.

They failed to justify their 500% price increase, their 600% increase in executive pay, or their tax-dodging move of corporate offices to the Netherlands.1

Join our campaign to tell the FTC to investigate Mylan for price-gouging and anti-competitive behavior.

Since acquiring the product in 2007, Mylan has raised the price of an EpiPen two-pack from a little over $90 to more than $600.2

Imagine you’re the parent of a child who suffers severe allergic reactions.